{
    "code": "02021575",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021575",
    "time": "2019-04-12 03:43:50",
    "許可證字號": "衛署藥輸字第021575號",
    "註銷狀態": "已註銷",
    "註銷日期": "107\/07\/03",
    "註銷理由": "自請註銷",
    "有效日期": "108\/03\/07",
    "發證日期": "86\/03\/11",
    "許可證種類": "製　劑",
    "舊證字號": "02017889",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202157509",
    "中文品名": "舒培盟注射液",
    "英文品名": "SUPREMON INJECTABLE SOLUTION",
    "適應症": "前列腺癌",
    "劑型": "270注射劑",
    "包裝": "小瓶",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "BUSERELIN(ACETATE)"
    ],
    "限制項目": "",
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F470328000  SANOFI-AVENTIS DEUTSCHLAND GMBH",
        "製造廠廠址": "BRUNINGSTRASSE 50 D-65926 FRANKFURT (MAIN), GERMANY.",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6818009410",
            "成分名稱": "BUSERELIN (ACETATE)",
            "含量描述": "(1.050MG) 1.000",
            "含量": "",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Supremon Injection_LPI_C_CCDS v8_clean (TW-V4)-104-05-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021575&Seq=030&Type=9"
        },
        {
            "title": "Supremon Inj_box-104-09-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021575&Seq=004&Type=8"
        }
    ]
}